Virginia attracted $12 billion in pharmaceutical manufacturing investments in 2025, leveraging site readiness, workforce ...

Royalty Pharma plc has completed a transaction to monetize remaining fixed payments on the MorphoSys Development Funding Bonds for $511 million in cash, resulting in total proceeds of $530 million ...

Lantern has successfully confirmed PTGR1 as a key biomarker that it intends to use to optimize patient selection based on potential tumor sensitivity to the drug candidate LP-184. LP-184 is a ...

Total proceeds of $530 million on $300 million original 2022 investment Proceeds strengthen balance sheet and provide added flexibility to pursue disciplined capital allocation strategy, including ...

The pharmaceutical industry is experiencing its own “DeepSeek moment,” according to science writer Hiya Jain. Just as the upstart AI breakthrough caught Silicon Valley off-guard, China is emerging as ...

Ironwood Pharmaceuticals is downgraded from a 'Buy' to a 'Sell' due to pipeline setbacks and declining LINZESS sales. Click ...

On the back of its $350 million deal for two late-stage Idorsia assets, Viatris will continue to be “opportunistic” when it comes to making future business development grabs—especially on the ...

Pharmaceutical Contract Development And Manufacturing Organization Cdmo Market Pharmaceutical Contract Development · GlobeNewswire Inc. Dublin, Feb. 03, 2026 (GLOBE NEWSWIRE) -- The "Pharmaceutical ...

The MarketWatch News Department was not involved in the creation of this content. -- Sophie Lamle brings over 20 years of experience in the pharmaceutical industry, leading innovation, clinical ...

The MarketWatch News Department was not involved in the creation of this content. -- SK Capital Partners have signed a definitive agreement to divest the Noramco API related assets in a sale to ...

In recent years, pharmaceutical companies have broadened their horizons, moving beyond drug development to enter the medical device market. This strategic shift allows pharma to offer integrated ...